Introduction {#s1}
============

Invariant natural killer T (iNKT) cells represent a unique T-cell lineage with the ability to bridge innate and adaptive immune responses \[[@B1]-[@B4]\]. *i*NKT cells express the invariant Vα14-Jα18 TCR (*i*Vα14TCR) in mice and the Vα24-Jα18 TCR in humans, with limited TCRVβ usages. *i*NKT cells are positively selected in the thymus after the engagement of the *i*Vα14TCR with glycolipids presented by CD1d expressed on CD4^+^CD8^+^ double-positive (DP) thymocytes \[[@B5]-[@B8]\]. Post-selected *i*NKT cells undergo defined developmental stages, including stage 1 (CD44^-^NK1.1^-^), stage 2 (CD44^+^NK1.1^-^), and terminally differentiated stage 3 (CD44^+^NK1.1^+^) \[[@B5],[@B6],[@B9],[@B10]\]. Different from conventional αβ T cells, *i*NKT cells rapidly produce copious amounts of cytokines such as IL-4, IFNγ, and TNFα following stimulation of the *i*Vα14TCR with agonist ligands, such as α-galactosylceramide (α-GalCer) and endogenous and microbial ligands \[[@B11]-[@B14]\].

Recently, *i*NKT cells capable of producing the IL-17 family of cytokines (*i*NKT-17), such as IL-17A, IL-17F, and IL-22, have been identified \[[@B15]-[@B18]\]. *i*NKT cell-derived IL-17-family cytokines are implicated in both inflammatory responses such as airway inflammation via recruiting neutrophils and protective roles such as suppression of liver inflammation \[[@B19],[@B20]\]. *i*NKT-17 cells are generated in the thymus and are considered to be developmentally programmed \[[@B17],[@B21]\]. *i*NKT-17 cells are mainly restricted to the NK1.1^-^ CD4^-^ population \[[@B15]\] and express the marker for recent thymic emigrant and nature-regulatory T cells neuropilin-1 \[[@B16]\]. Additionally, *i*NKT-17 cells express molecules that are usually characteristic of Th17 cells such as the orphan nuclear receptor RORγt, the IL-23 receptor (IL-23R), and the chemokine receptor CCR6 \[[@B17],[@B22],[@B23]\]. Although it has become clear that *i*NKT-17 represents a unique *i*NKT sublineage with important functions in the pathogenesis of diseases, the signal control for the generation/maintenance of this sublineage of *i*NKT cells is not well understood.

Diacyglcerol kinase ζ (DGKζ) belongs to a family of 10 enzymes that phosphorylate diacylglycerol (DAG) to produce phosphatidic acid (PA), two important second messengers involved in signaling from numerous receptors \[[@B24]-[@B26]\]. DGKζ is expressed in many cell lineages in the immune system, such as T cells, macrophages, dendritic cells, and mast cells \[[@B27]-[@B30]\]. Recent studies have demonstrated that DGK activity plays important regulatory roles in these immune-cell lineages via terminating DAG and simultaneously generating PA \[[@B28],[@B29],[@B31]\]. In T cells, DGKζ negatively controls TCR-induced activation of the RasGRP1-Ras-Erk1/2 pathway, the PKCθ-NFκB pathway, and mTOR signaling \[[@B27],[@B30],[@B32],[@B33]\], inhibits T cell activation *in vitro* and *in vivo* \[[@B27],[@B30]\], inhibits primary anti-viral immune responses but promotes memory CD8 T-cell-mediated anti-viral immune responses \[[@B34]\], contributes to T-cell anergy and tumor evasion \[[@B31]\], and, together with DGKα, promotes the positive selection of conventional αβ T (cαβT) cells \[[@B35]\]. DGKζ has also been demonstrated to regulate TLR signaling and the production of proinflammatory cytokines such as IL-12p40 and TNFα to control innate and adaptive immune responses to parasite infection \[[@B26]\] and to modulate mast-cell survival and activation \[[@B29]\]. Recently, we have demonstrated that deficiency of both DGKζ and α, another isoform expressed in T cells, causes severe decreases of *i*NKT cells in mice \[[@B33]\]. However, deficiency of either DGKα or DGKζ alone does not result in a noticeable abnormality of *i*NKT-cell numbers in mice. In this report, we demonstrate that germline deficiency of DGKζ leads to decreases of IL-17 producing *i*NKT cells without an obvious effect on IL-4- and IFNγ-producing *i*NKT (*i*NKT-4 and -1) cells. The decrease of *i*NKT-17 cells caused by DGKζ deficiency is correlated with a reduced expression of RORγt and IL-23R. Interestingly, in chimeric mice reconstituted with mixed WT and DGKζ bone marrow (BM) cells, an *i*NKT-17 defect caused by DGKζ deficiency can be corrected, suggesting that DGKζ controls *i*NKT-17 development via *i*NKT extrinsic mechanisms.

Methods {#s2}
=======

Mice and cells {#s2.1}
--------------

DGKζ-deficient (DGKζKO) mice backcrossed to C57BL/6J background for at least nine generations were previously reported \[[@B27],[@B31]\]. C57BL/6J and CD45.1^+^ congenic mice were generated by in-house breeding. TCRαKO mice were purchased from the Jackson Laboratory. All mice were housed in a pathogen-free facility. This study was carried out in strict accordance with the recommendations in the *Guide for the Care and Use of Laboratory Animals of the National Institutes of Health*. All mice were used according to protocols approved by the Institutional Animal Care and Use Committee of Duke University (Protocol Number: A132-10-5). Splenocytes, thymocytes, and liver MNCs were made according to previously published protocols \[[@B33],[@B36]\].

Antibodies and flow cytometry {#s2.2}
-----------------------------

Iscove's Modified Dulbecco's Medium (IMDM) was supplemented with 10% (vol/vol) FBS, penicillin/streptomycin, and 50 µM 2-mercaptoethanol (IMDM-10). PE- or APC-conjugated mouse CD1d tetramers loaded with PBS-57 were provided by the NIH Tetramer Facility. The Live/Dead^®^ Fixable Violet Dead Cell Stain Kit was purchased from Invitrogen. Fluorescence-conjugated anti-mouse TCRβ (H57-597), CD45.1 (A20), Thy1.2 (30-H12), IFNγ (XMG1.2), IL-17A (TC11-18 H10.1), IL-4 (11B11), and RORγt (ATKJS-9) antibodies were purchased from BioLegend.

Cell-surface staining was performed with 2% FBS-PBS. Intracellular staining for IFNγ, IL-17A, and IL-4 was performed using BD Biosciences Cytofix/Cytoperm^™^ and perm/wash solutions following the manufacturer's protocol. All flow cytometry data were collected using FACS Canto-II (BD Biosciences) and analyzed with the FlowJo software. A solution of 0.5% Tween-20-PBS was used to dissolve α-GalCer (Enzo life science).

Purification of *i*NKT cells and real-time quantitative PCR {#s2.3}
-----------------------------------------------------------

*i*NKT cells were enriched with PE-CD1dTet and anti-PE-MACS-beads according to a previously published protocol \[[@B33],[@B36]\]. Enriched *i*NKT cells were stained with anti-TCRβ and 7-AAD and sorted for live CD1dTet ^+^ TCRβ^+^ *i*NKT cells with greater than 98% purity using MoFlo. Sorted *i*NKT cells were immediately lysed in Trizol for RNA preparation. cDNA was made using the iScript Select cDNA Synthesis Kit (Biorad). Real-time quantitative PCR was conducted and analyzed as previously described \[[@B33],[@B36]\]. Expressed levels of target mRNAs were normalized with β-actin and calculated using the 2^--ΔΔCT^ method. Primers were as follows: IL-23R, Forward: 5'-AGCAAAATCATCCCACGAAC-3', Reverse: 5'- GAAGACCATTCCCGACAAAA-3'; RORc, Forward: 5'-CGACTGGAGGACCTTCTACG-3', Reverse: 5'-TTGGCAAACTCCACCACATA-3'; IFN-γ, Forward: 5'-GCGTCATTGAATCACACCTG-3', Reverse: 5'-TGAGCTCATTGAATGCTTGG-3'; IL-4, Forward: 5'-ACAGGAGAAGGGACGCCAT-3', Reverse: 5'-GAAGCCCTACAGACGAGCTCA-3'; IL-17A, Forward: 5'-GCTCCACAAGGCCCTCAGA-3', Reverse: 5'-CTTTCCCTCCGCATTGACA-3'; DGK-α, Forward: 5'-GATGCAGGCACCCTGTACAAT-3', Reverse: 5'-GGACCCATAAGCATAGGCATCT-3'; DGK-ζ, Forward: 5'-CTGAGGAGCAGATCCAGA GC-3'; DGK-δ, Forward: 5'-GATCCTCGAGCCTCTGCGTTCTCTGC-3', Reverse: 5'-GATCGCGGCCGCGGCCAGAACACAT-3'.

In vitro stimulation of *i*NKT cells {#s2.4}
------------------------------------

For α-GalCer stimulation, 1 x 10^7^ thymocytes, 5 x 10^6^ splenocytes, or 5 x 10^6^ lymph node (LN) cells were seeded in a 48-well plate in 1 ml IMDM-10 or 5 x 10^5^ liver MNCs were seeded in a 96-well plate in 200 µl IMDM-10. Cells were left unstimulated or stimulated with α-GalCer (125 ng/ml) for 72 hours with the addition of PMA (50 ng/ml) and ionomycin (500 ng/ml) and GolgiPlug™ (1ng/ml) in the last 5 hours. For short-term PMA plus ionomycin stimulation, 0.5-1 x 10^6^ enriched *i*NKT cells from thymocytes and splenocytes or density-enriched liver MNCs were seeded in a 96-well V-bottom plate in 200 µl IMDM-10. Cells were stimulated with PMA plus ionomycin for 5 hours in the presence of GolgiPlug™. After stimulation, cells were first stained with CD1dTet, anti-TCRβ, anti-Lin (B220, Gr1, CD1b, CD11c, and CD8), and Live/Dead followed by intracellular staining for IFNγ, IL-17A, IL-4, and RORγt. *i*NKT cells were gated on live B220^-^, Gr1^-^, CD11b^-^, CD11c^-^, and CD8^-^ cells.

In vivo stimulation of *i*NKT cells {#s2.5}
-----------------------------------

Mice were intraperitoneally injected with 150 µg Brefeldin A in 100 µl. Ninety minutes later, mice were intraperitoneally injected with 2 µg α-GalCer diluted in 200 µl PBS. Two hours after the α-GalCer injection, splenocytes and liver MNCs were intracellularly stained for IFNγ, IL-4, and IL-17A. Total RNA from splenocytes was also isolated from mice injected with α-GalCer without a Brefeldin A pretreatment.

Bone marrow chimeric mice {#s2.6}
-------------------------

*TCRα* ^*-/-*^ mice were sublethally irradiated (600 rad) and intravenously injected with a mixture of WT (CD45.1^+^) and DGKζKO (CD45.2^+^) BM cells at a 1:2 ratio. Thymocytes and splenocytes from the recipient mice were harvested 8 weeks later.

Statistical analysis {#s2.7}
--------------------

Data are presented as mean ± SEM and statistical significance were determined by a Student's *t*-test.

Results {#s3}
=======

*DGKζ* deficiency does not affect *i*NKT cell proliferation *in vitro* {#s3.1}
----------------------------------------------------------------------

DGKα, ζ, and δ are the dominant isoforms that expressed in T cells \[[@B25],[@B31]\]. We compared the expression of these isoforms between cαβT cells and *i*NKT cells. As shown in [Figure 1A](#pone-0075202-g001){ref-type="fig"}, both DGKα and δ were expressed at reduced levels in *i*NKT cells compared with CD8^+^ cαβT cells. However, DGKζ was expressed at a higher level in *i*NKT cells than in CD8^+^ T cells. The reason for the differential expression of DGK isoforms between cαβT and *i*NKT cells remains to be defined.

![DGKζ is dispensable for *i*NKT cell activation in vitro.\
(**A**) Quantitative real-time PCR analysis of DGK-α, ζ and δ mRNA in sorted CD8 cαβT cells and *i*NKT cells from wild-type mice. Data are representative of three independent experiments. \*\*, *P* \< 0.01, and \*\*\*, *P* \< 0.001 determined unpaired two-tail Student *t*-test. (**B**) *i*NKT cell proliferation assessed by CFSE-dilution assay. CFSE-labeled WT and DGKζKO thymoyctes were left unstimulated or stimuated with α-Galcer in vitro for 72 hours. Overlaid histograms show CFSE intensity in live gated CD1dTet ^+^ TCRβ^+^ *i*NKT cells. Data shown represent three experiments.](pone.0075202.g001){#pone-0075202-g001}

Previously, studies have demonstrated that a deficiency of DGKζ does not affect *i*NKT-cell development. The total numbers and developmental stages of *i*NKT cells in DGKζKO mice are not obviously different from WT control mice \[[@B33]\]. To examine whether DGKζ regulates *i*NKT-cell activation *in vitro*, we labeled WT and DGKζ deficient thymocytes with CFSE and then stimulated the cells with α-GalCer in vitro for 72 hours. As shown in [Figure 1B](#pone-0075202-g001){ref-type="fig"}, DGKζKO and WT *i*NKT cells expanded and proliferated similarly, suggesting that DGKζ deficiency did not affect TCR-induced *i*NKT- cell proliferative response *in vitro*. It has been demonstrated that DGKζKO cαβT cells are hyperproliferative in response to TCR stimulation \[[@B27]\]. Thus, DGKζ differentially controls cαβT and *i*NKT-cell proliferation *in vitro*.

Decreased IL-17 but not IFNγ or IL-4 production by *DGKζ* deficient *i*NKT cells following in vitro stimulation of the *i*Vα14TCR {#s3.2}
---------------------------------------------------------------------------------------------------------------------------------

*i*NKT cells produce multiple cytokines to regulate immune responses. To determine whether DGKζ regulates cytokine production by *i*NKT cells during *in vitro* activation, we stimulated WT and DGKζKO thymocytes with α-GalCer for 48 and 72 hours; IFNγ, IL-4, and IL-17 levels in culture supernatants were measured by ELISA. No obvious differences of IFNγ and IL-4 levels were observed between WT and DGKζKO *i*NKT cells. In contrast, IL-17A levels were considerably decreased in DGKζ *i*NKT cells ([Figure 2A](#pone-0075202-g002){ref-type="fig"}). Consistent with these ELISA data, intracellular staining of these cytokines in *i*NKT cells also showed decreased IL-17A but similar IFNγ- and IL-4-producing *i*NKT cells following α-GalCer stimulation ([Figure 2B and 2C](#pone-0075202-g002){ref-type="fig"}). Taken together, these data indicate that DGKζ plays an important role for IL-17 production by *i*NKT cells *in vitro*.

![Decreased IL-17A production by DGKζ deficient *i*NKT cells following α-GalCer stimulation in vitro.\
Thymocytes, splenocytes, and liver mononuclear cells (MNC) from WT, *DGKζ* ^*-/-*^ mice were stimulated with α-GalCer for 72 hours *in* *vitro*. (**A**) IL-4, IFNγ, and IL-17A levels in culture supernatants of thymocytes measured by ELISA. (**B**) Intracellular staining of IL-4, IFNγ, and IL-17A of thymic, splenic, liver, and lymph node (LN) *i*NKT cells stimulated with α-GalCer for 72 hours with PMA and ionomycin in the presence of GolgiPlug during the last 5 hours of culture. (**C**) Percentages of thymic *i*NKT cells producing the indicated cytokines. Bar graphs are mean ± SEM calculated from three experiments.](pone.0075202.g002){#pone-0075202-g002}

Impaired *i*NKT-17 development in the absence of DGKζ {#s3.3}
-----------------------------------------------------

The impaired production of IL-17A by *i*NKT cells following α-GalCer stimulation can be caused by a developmental defect or impaired expansion of *i*NKT-17 cells. To determine whether DGKζ deficiency causes a developmental defect in generating *i*NKT-17 cells, we enriched *i*NKT cells from WT and DGKζKO thymocytes and stimulated enriched *i*NKT cells with PMA plus ionomycin *in vitro* for 5 hours in the presence of GolgiPlug. Intracellular staining of cytokines showed decreased IL-17A positive cells within DGKζKO *i*NKT cells than in WT controls ([Figure 3A and 3B](#pone-0075202-g003){ref-type="fig"}). In contrast, the percentages of IFNγ- and IL-4-producing cells were similar in WT and DGKζKO *i*NKT cells. RORγt and IL-23R signaling is critical for the *i*NKT-17 differentiation \[[@B17],[@B22]\]. We sorted *i*NKT cells from WT and DGK-ζKO thymocytes and measured RORγt and IL-23R mRNA levels by quantitative real-time PCR. Consistent with the *i*NKT-17 developmental defect, IL-23R and RORγt mRNA levels were obviously decreased in DGKζKO *i*NKT cells compared with WT *i*NKT cells ([Figure 3C](#pone-0075202-g003){ref-type="fig"}). Consistent with these observations, DGKζKO thymic *i*NKT cells contained much less IL-17A ^+^ RORγ^+^ double positive cells than WT controls ([Figure 3D](#pone-0075202-g003){ref-type="fig"}). Together, these results suggest that DGKζ at least promotes *i*NKT-17 differentiation during development.

![*i*NKT-17 developmental defect in the absence of DGKζ.\
(**A**,**B**) *i*NKT-cells enriched from WT and DGKζKO thymocytes, splenocytes, liver mononuclear cells, and LN cells were stimulated with PMA and ionomycin for 5 hours in the presence of Golgi-Plug. Contour plots show intracellular staining of indicated cytokines in gated CD1dTet ^+^ TCRβ ^+^ Lin^-^(Gr1^-^B220^-^CD8^-^CD11c^-^CD11b^-^) *i*NKT cells (A). Bar graph (B) represents mean ± SEM of percentages of indicated cytokines in gated *i*NKT-cells (n=3). (**C**) Decreased RORγt and IL23R expression in DGKζKO *i*NKT cells. RORγt and IL23R mRNA levels in sorted thymi *i*NKT cells from WT and DGKζKO mice were measured by quantitative real-time PCR. \*, *P*\<0.05; \*\*\*, *P* \< 0.001 (*t*-test). (**D**) Co-intracellular staining of IL-17A and RORγt in thymic WT and DGKζKO *i*NKT cells following PMA + ionomycin stimulation for 5 hours. Data shown are representative or calculated from three experiments.](pone.0075202.g003){#pone-0075202-g003}

Impaired *in vivo* IL-17 induction in DGKζ deficiency mice following α-GalCer treatment {#s3.4}
---------------------------------------------------------------------------------------

The data shown above reveal the important role of DGKζ of IL-17 production *in vitro*. We further examined how DGKζ deficiency may affect *i*NKT-cell cytokine production *in vivo*. As shown in [Figure 4A and 4B](#pone-0075202-g004){ref-type="fig"}, intracellular staining showed that the percentages of IL-4 or IFNγ positive *i*NKT cells were similar between WT and DGKζKO mice 2 hours after the α-GalCer injection. However, the percentage of IL-17-producing *i*NKT cells was obviously lower in DGKζKO mice than in WT mice. Moreover, the IL-17A mRNA level, although not IL-4 or IFNγ mRNA levels, was decreased in the DGKζKO spleen after the α-GalCer injection ([Figure 4C](#pone-0075202-g004){ref-type="fig"}). Together, these observations suggest that DGKζ is important for optimal IL-17 expression in *i*NKT cells *in vivo*.

![Decreased IL-17A expression following *i*NKT cell activation *in vivo*.\
WT and DGKζKO mice were intraperitoneally injected with 150µg brefeldin A. Ninety minutes later, mice were intraperitoneally injected with 2 µg α-GalCer diluted in 200 µl PBS. Two hours after α-GalCer injection, IFN-γ, IL-4, and IL-17A positive *i*NKT cells in the spleen and liver were determined by flow-cytometry. (**A**) Representative dot plots show intracellularly stained cytokines in gated *i*NKT cells expression. (**B**) Mean ± SEM presentation of *i*NKT cells expressing the indicated cytokines. (**C**) Decreased IL-17A mRNA in DGKζKO spleen 4 hours after α-GalCer injection. Data shown represent two experiments.](pone.0075202.g004){#pone-0075202-g004}

Promotion of *i*NKT-17 differentiation by DGKζ is not *i*NKT cell intrinsic {#s3.5}
---------------------------------------------------------------------------

Because DGKζ was deficient in all cell lineages in DGKζKO mice, the aforementioned *i*NKT-17 defect in these mice could be caused by extrinsic or intrinsic mechanisms. To distinguish these possibilities, we generated mixed-bone-marrow chimeric mice by co-injecting CD45.1^+^ WT and CD45.2^+^ DGKζKO BM cells at a 1:2 ratio into sublethally irradiated *TCRα* ^*-/-*^ mice. Eight weeks after reconstitution, *i*NKT cells from thymocytes or splenocytes of the chimeric mice were enriched and stimulated with PMA plus ionomycin for 5 hours or stimulated with α-GalCer for 72 hours to induce IL-17 and IFNγ production. As shown in [Figure 5](#pone-0075202-g005){ref-type="fig"}, similar percentages of DGKζKO and WT *i*NKT cells produced IL-17A, suggesting that the impairment of *i*NKT-17 differentiation caused by DGKζ deficiency likely resulted from mechanisms extrinsic to *i*NKT cells.

![*i*NKT-17 developmental defect in DGKζ deficiency mice is due to cell extrinsic mechanism.\
Sublethally irradiated *TCRα* ^*-/-*^ mice were i.v. injected with WT (CD45.1) and DGKζ KO (CD45.2) BM cells at a 1:2 ratio. (**A**) Enriched *i*NKT-cells from thymocytes or splenocytes from chimeric mice stimulated with PMA and Ionomycin for 5 hours in the presence of a GolgiPlug. Intracellular IL-17 and IFNγ staining in WT and DGKζ KO *i*NKT-cells were gated in *i*NKT-cells. (**B**) Ten million WT and DGK-ζ KO thymocytes stimulated with α-GalCer for 72 hours. Intracellular IL-17 and IFNγ staining in WT and DGKζ KO *i*NKT-cells were gated in *i*NKT-cells. Data shown are representative of three chimeras from two independent experiments.](pone.0075202.g005){#pone-0075202-g005}

Discussion {#s4}
==========

In this report, we demonstrated that DGKζ plays a selective role in promoting *i*NKT-17 development. We have shown that a deficiency of DGKζ resulted in impaired *i*NKT-17 correlated with decreased expression of RORγt and IL-23R. In contrast, IFNγ-producing *i*NKT-1 or IL-4-producing *i*NKT-4 cell development seemed not to be affected by DGKζ activity.

At least three DGK isoforms, α, δ, and ζ, are expressed in *i*NKT cells. While sharing common structural features such as the kinase domain and the cysteine-rich C1 domains, they also contain distinct structural domains/motifs and belong to different subtypes of the DGK family \[[@B37]\]. We have demonstrated that DGKα and ζ function synergistically to promote *i*NKT-cell development/homeostasis and cαβ T cell maturation \[[@B33],[@B35]\]. Additionally, deficiency of either DGKα or ζ results in enhanced activation of cαβT-cell activation reflected by hyper-proliferation and elevated cytokine production \[[@B27],[@B31]\]. However, DGKζ deficiency does not obviously impact *i*NKT cell activation. DGKζ-deficient *i*NKT cells proliferate and secrete IFNγ and IL-4 similarly to WT *i*NKT cells following TCR engagement. Thus, *i*NKT cells and cαβT cells display a differential requirement of DGKζ for modulating their activation. At present, we cannot rule out that DGKα or δ may function redundantly with DGKζ in the control of *i*NKT cell activation. The virtual absence of *i*NKT cells in DGKα and ζ double-deficient mice prevents us from addressing this issue. Further generation and analysis of mice with conditional ablation of multiple DGK isoforms in mature *i*NKT cells should provide a solid conclusion regarding the role of DGK activity in *i*NKT cell activation.

Our data indicate that DGKζ promotes *i*NKT-17 differentiation via *i*NKT-extrinsic mechanisms. Important questions remain to be addressed about which cell lineage DGKζ controls *i*NKT-17 differentiation and how DGKζ exerts such functions in this cell lineage. *i*NKT-17 development is intrinsically dependent on RORγt but is negatively controlled by Th-POK, a transcript factor critical for CD4 lineage development \[[@B17],[@B21],[@B38],[@B39]\]. Extracellular factors such as IL-23 and IL-1 are indispensable for *i*NKT-17 differentiation \[[@B22],[@B40]\]. Interestingly, we have found that DGKζ is important for IL-12p40 expression in macrophages and dendritic cells \[[@B28]\]. A decrease of expression of IL-12p40, a subunit for both IL-12 and IL-23, could potentially lead to impaired *i*NKT-17 differentiation. Additionally, DGK activity inhibits mTOR activation in T cells \[[@B32]\]. mTOR activity can negatively control IL-12p40 transcription in dendritic cells and macrophages \[[@B41]-[@B44]\]. Thus, it is possible that a potential elevation of mTOR activity in dendritic cells may cause down-regulation of IL-23 expression by dendritic cells, leading to impaired *i*NKT-17 differentiation. Future studies using DGKζ conditional knockout mice should help to identify the lineage in which, and the mechanisms by which, DGKζ functions to promote *i*NKT-17 differentiation.
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